BBLG - Bone Biologics Corp

1.28
0.060   4.688%

Share volume: 27,734
Last Updated: 03-06-2026
Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies: -0.03%

PREVIOUS CLOSE
CHG
CHG%
$1.22
0.06
0.05%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
33%
Profitability 35%
Dept financing 22%
Liquidity 50%
Performance 30%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
1.75%
1 Month
-9.86%
3 Months
-32.28%
6 Months
-40.47%
1 Year
56.63%
2 Year
-46.89%
Key data
Stock price
$1.28
P/E Ratio 
0.00
DAY RANGE
$1.18 - $1.28
EPS 
-$4.39
52 WEEK RANGE
$0.57 - $6.75
52 WEEK CHANGE
$56.63
MARKET CAP 
7.930 M
YIELD 
N/A
SHARES OUTSTANDING 
1.795 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
05-13-2025
BETA 
1.74
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$39,599
AVERAGE 30 VOLUME 
$26,393
Company detail
CEO: Jeffrey Frelick
Region: US
Website: bonebiologics.com
Employees: 2
IPO year: 2026
Issue type: Common Stock
Market: XNAS
Industry: Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies
Sector: Manufacturing

Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein. The company was founded in 2004 and is headquartered in Burlington, Massachusetts.

Recent news